An overview of the pharmacokinetics, efficacy and safety of liraglutide.

@article{Bode2012AnOO,
  title={An overview of the pharmacokinetics, efficacy and safety of liraglutide.},
  author={Bruce W Bode},
  journal={Diabetes research and clinical practice},
  year={2012},
  volume={97 1},
  pages={
          27-42
        }
}
OBJECTIVE Incretin-based therapies, including glucagon-like peptide 1 (GLP-1) receptor agonists, are the latest addition to the range of available medications for the management of patients with type 2 diabetes. The GLP-1 analog liraglutide has been approved for use in Europe and the US for over a year and has undergone evaluation in several pharmacokinetic/pharmacodynamics studies and in an extensive phase 3 clinical program. The aim of this review is to assess the pharmacokinetics, efficacy… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 24 CITATIONS

Similar Papers

Loading similar papers…